http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2004235806-A1
Outgoing Links
Predicate | Object |
---|---|
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-138 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-138 |
filingDate | 2004-02-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_85f8955096c57670806f02b8cc77bb44 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba8ded4f078a7bff418b29048ba13499 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f1e5e33ad157a5e4079790a9b60d6590 |
publicationDate | 2004-11-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | US-2004235806-A1 |
titleOfInvention | Prevention and treatment of androgen - deprivation induced osteoporosis |
abstract | This invention provides: 1) a method of treating androgen-deprivation induced osteoporosis and/or bone fractures and/or loss of Bone Mineral Density (BMD) in a male subject suffering from prostate cancer; 2) a method of preventing androgen-deprivation induced osteoporosis and/or bone fractures and/or loss of Bone Mineral Density (BMD) in a male subject suffering from prostate cancer; 3) a method of suppressing or inhibiting androgen-deprivation induced osteoporosis and/or bone fractures and/or loss of BMD in a male subject suffering from prostate cancer; and 4) a method of reducing the risk of developing androgen-deprivation induced osteoporosis and/or bone fractures and/or loss of BMD in a male subject suffering from prostate cancer, by administering to the subject a pharmaceutical composition comprising an anti-estrogen agent and/or its analog, derivative, isomer, metabolite, pharmaceutically acceptable salt, pharmaceutical product, hydrate, N-oxide, or any combination thereof. |
priorityDate | 2001-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 311.